Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03224468 · ClinicalTrials.gov registry record · NA
Effect of Medical Marijuana on Neurocognition and Escalation of Use
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 269
- Enrollment target
NCT03224468: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03224468 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 269 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03224468, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 269 participants
- Enrollment target
Study Summary
This study will use a randomized controlled design to test whether patients who use medical marijuana, compared to a waitlist control group, experience a change in health outcomes (relief of symptoms, or adverse health outcomes such as new-onset symptoms of cannabis use disorders, neurocognitive impairments) or brain-based changes.
Interventions
- DRUG Medical Marijuana
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 269 participants |
| Start Date | 2017-07-01 |
| Est. Completion | 2022-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03224468
The ClinicalTrials.gov registry entry for NCT03224468 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 269 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medical Marijuana is the first listed.
NCT03224468 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03224468 about?
NCT03224468 is a clinical study titled "Effect of Medical Marijuana on Neurocognition and Escalation of Use". This study will use a randomized controlled design to test whether patients who use medical marijuana, compared to a waitlist control group, experience a change in health outcomes (relief of symptoms, or adverse health outcomes such as new-onset symptoms of cannabis use disorders, neurocognitive imp...
What is the current status of trial NCT03224468?
This trial is currently completed. It is a NA study. The enrollment target is 269 participants. The study started on 2017-07-01. Estimated completion is 2022-11-01.
What interventions are being tested in trial NCT03224468?
The interventions under investigation include: Medical Marijuana (DRUG).
Who is sponsoring clinical trial NCT03224468?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.